Id |
Subject |
Object |
Predicate |
Lexical cue |
S1 |
0-279 |
Sentence |
denotes |
Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. |
S2 |
280-397 |
Sentence |
denotes |
BACKGROUND: The Bcl-6 gene product, a nuclear phosphoprotein, is expressed independently of Bcl-6 gene rearrangement. |
S3 |
398-539 |
Sentence |
denotes |
In lymph nodes, expression of Bcl-6 protein is restricted to germinal center (GC) B-cells and 10% to 15% of CD3/CD4+ intrafollicular T cells. |
S4 |
540-628 |
Sentence |
denotes |
Interfollicular cells are negative for Bcl-6 protein, except for rare CD3+/CD4+ T cells. |
S5 |
629-893 |
Sentence |
denotes |
Recently, we reported cases of angioimmunoblastic T-cell lymphoma (AITL) with hyperplastic GCs (AITL/GC), and observed that borders of enlarged GCs were ill defined, with features suggestive of an outward migration of GC cells to surrounding interfollicular zones. |
S6 |
894-1043 |
Sentence |
denotes |
This prompted a study of follicular borders with Bcl-6 staining in reactive follicular hyperplasias and follicular lymphomas to compare with AITL/GC. |
S7 |
1044-1138 |
Sentence |
denotes |
MATERIALS AND METHODS: Formalin-fixed paraffin sections were used for immunostaining of Bcl-6. |
S8 |
1139-1315 |
Sentence |
denotes |
Six cases of AITL/GC, 12 nonspecific reactive follicular hyperplasia (FH), 7 HIV adenopathy, 10 follicular lymphoma (FL), and 8 typical AITL (ie, AITL without GC) were studied. |
S9 |
1316-1406 |
Sentence |
denotes |
Double staining for Bcl-6/CD20, Bcl-6/CD3, and Bcl-6/CD57 was performed in selected cases. |
S10 |
1407-1594 |
Sentence |
denotes |
RESULTS: In FH and HIV adenopathy, staining for Bcl-6 revealed densely populated GCs with well-defined and regular GC borders, whereas Bcl-6+ cells were rare in the interfollicular areas. |
S11 |
1595-1758 |
Sentence |
denotes |
An occasional GC with an ill-defined border was invariably surrounded by a broad mantle zone; those with indistinct mantle zones had well-defined, regular borders. |
S12 |
1759-1886 |
Sentence |
denotes |
In FL, follicles were densely populated, and their borders were irregular, with some Bcl-6+ cells in the interfollicular zones. |
S13 |
1887-2033 |
Sentence |
denotes |
In AITL/GC, GCs were less dense, GC borders were ill defined and irregular, and the number of interfollicular Bcl-6+ cells was markedly increased. |
S14 |
2034-2146 |
Sentence |
denotes |
Double staining revealed that these interfollicular Bcl-6+ cells in AITL/GC were Bcl6+/CD3+/CD20-/CD57- T cells. |
S15 |
2147-2245 |
Sentence |
denotes |
Moreover, CD3+ intrafollicular T cells were depleted in AITL/GC, whereas they were abundant in FH. |
S16 |
2246-2333 |
Sentence |
denotes |
Intrafollicular CD57+ cells did not stain for Bcl-6, and were also depleted in AITL/GC. |
S17 |
2334-2435 |
Sentence |
denotes |
In typical AITL, some neoplastic cells were positive for Bcl-6, showing variable degrees of staining. |
S18 |
2436-2606 |
Sentence |
denotes |
CONCLUSIONS: (1) GCs of AITL/GC differed from those of other reactive follicular hyperplasias and follicular lymphomas, and staining for Bcl-6 was useful to discern them. |
S19 |
2607-2847 |
Sentence |
denotes |
(2) Intrafollicular CD3+ T cells, many of which were also positive for Bcl-6, were markedly depleted in AITL/GC, with increased interfollicular Bcl-6+/CD3+ cells, suggesting an outward migration of intrafollicular T cells in this condition. |
S20 |
2848-2986 |
Sentence |
denotes |
(3) Interfollicular Bcl-6+/CD3+ cells in AITL/GC were too numerous to be accounted for by migration alone, suggesting local proliferation. |
S21 |
2987-3110 |
Sentence |
denotes |
(4) Intrafollicular CD57+ cells were negative for Bcl-6, indicating heterogeneity of the intrafollicular T-cell population. |
S22 |
3111-3223 |
Sentence |
denotes |
(5) Some neoplastic cells in AITL stained for Bcl-6, suggesting up-regulation of Bcl-6 expression in this tumor. |